Advertisement
U.S. Markets closed
S&P Futures
5,878.50 +32.50 (+0.56%) Dow Futures
42,514.00 +193.00 (+0.46%) Nasdaq Futures
20,637.75 +139.00 (+0.68%) Russell 2000 Futures
2,234.50 +13.00 (+0.59%) Crude Oil
68.36 -3.42 (-4.76%) Gold
2,740.10 -14.50 (-0.53%)
PROCEPT BioRobotics Corporation (PRCT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 66.83 |
| Open | 67.02 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 67.02 - 70.39 |
| 52 Week Range | 24.83 - 85.81 |
| Volume | |
| Avg. Volume | 734,128 |
| Market Cap | 3.571B |
| Beta (5Y Monthly) | 1.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.06 |
| Earnings Date | Oct 28, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 89.83 |
ZacksDown -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround
PROCEPT BioRobotics (PRCT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksEarnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.